A retrospective analysis of outcomes of rhino-orbito-cerebral mucormycosis at tertiary care hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20250687Keywords:
Amphotericin B, COVID-19, Mucormycosis, Rhino orbitalAbstract
Background: This study aimed to report outcomes of rhino-orbital-cerebral mucormycosis (ROCM) at tertiary care centre.
Methods: Retrospective analysis of in-patients diagnosed to have ROCM during the year 2021 was done. Diagnosis was confirmed based on lab and MRI investigations. Clinical features and management outcomes were noted.
Results: Among 113 suspected cases, 81 were confirmed to have ROCM. Majority of the patients had suffered COVID-19 disease. 67 cases out of 81 underwent maxillectomy with sinus debridement. Among the 67 cases,11 patients had orbital involvement with no PL, orbital exenteration was performed. Among remaining 14 patients, mortality due to cardiac and respiratory illness was seen in 3 patients, 7 went against advice and 4 had CNS involvement. All the patients were treated with liposomal amphotericin-B.
Conclusions: Early diagnosis, surgical intervention followed by amphotericin B in ROCM has favourable outcome. CNS involvement has a high mortality rate.
Metrics
References
Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis. 2012;54(1):S8-15. DOI: https://doi.org/10.1093/cid/cir864
Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10(1):31-47. DOI: https://doi.org/10.1111/j.1470-9465.2004.00843.x
Carvalho G, Mohanam TCVR, Jayachandran B, Prasanth HR. Rhino orbital mucormycosis- a case series. Int J Ocul Oncol Oculoplast. 2018;4(4):178-81. DOI: https://doi.org/10.18231/2581-5016.2018.0047
AK AK, Gupta V. Rhino-orbital cerebral mucormycosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
Chakrabarti SS, Kaur U, Aggarwal SK, Kanakan A, Saini A, Agrawal BK, et al. The pathogenetic dilemma of post-COVID-19 mucormycosis in India. Aging Dis. 2022;13(1):24. DOI: https://doi.org/10.14336/AD.2021.0811
Aggarwal SK, Kaur U, Talda D, Pandey A, Jaiswal S, Kanakan A, et al. Case report: rhino-orbital mucormycosis related to covid-19: a case series exploring risk factors. Am J Trop Med Hyg. 2021;106(2):566-70. DOI: https://doi.org/10.4269/ajtmh.21-0777
Rootman J, Robertson W, Lapointe JS. Inflammatory diseases. In: Rootman J, ed. Diseases of the Orbit. A Multidisciplinary Approach. 1st edn. J. B. Lippincott Company; 1988:55-56.
Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185:599-606. DOI: https://doi.org/10.1007/s11046-020-00462-9
Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol. 2021;69;244-52. DOI: https://doi.org/10.4103/ijo.IJO_3774_20
Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4). DOI: https://doi.org/10.1016/j.dsx.2021.05.019
Patel A, Kaur H, Xess L, Michael JS, Savio J, Rudramurthy S, et al. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020;26;944. DOI: https://doi.org/10.1016/j.cmi.2019.11.021
Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D’Souza O. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51;231-6.
Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the phoenix: Mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021;69(6);1563-8. DOI: https://doi.org/10.4103/ijo.IJO_310_21
Downloads
Published
How to Cite
Issue
Section
